TP53 and cancer: Nevertheless it has been shown that TP53 somatic mutations are present in about 30% of sporadic adult ACCs and almost never in ACAs [12] whereas, activating mutations of N-Ras gene have been observed in both benign and malignant adrenal cortical neoplasms with an incidence of 12.5% [13].